Paul Grayburn MD

Adult Congenital Heart Disease, Interventional Cardiology

Clinical Professor of Medicine, University Tex SW Dallas

621 N Hall StSuite H030Dallas, TX 75226
Phone+1 214-820-7500
Fax+1 214-820-7533

Dr. Grayburn is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Grayburn's full profile Already have an account?

Education & Training

University of Kentucky College of MedicineFellowship, Cardiovascular Disease, 1984 - 1987
University of Texas Southwestern Medical Center/St Paul Medical CenterResidency, Internal Medicine, 1981 - 1984
University of Texas Medical Branch School of MedicineClass of 1981

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

TX State Medical License 1981 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com
Fellow (FACC) American College of Cardiology

Clinical Trials

Impact of Medical and Surgical Therapy on Functional Mitral Regurgitation
COMPLETED
NA
Improving Echo Measurements in the Diagnosis of Aortic Stenosis
COMPLETED

Publications & Presentations

PubMed

TRISCEND II: Effect of Transcatheter Tricuspid Valve Replacement on Echocardiographic Measures of Right Heart Remodeling and Function.
Anna Sannino, Paul A Grayburn, Susheel K Kodali, Philipp Lurz, Vinod H Thourani
JACC. Cardiovascular Imaging. 2026-07-14
Five-year outcomes of transcatheter mitral valve replacement in patients with severe symptomatic mitral regurgitation: results from the Tendyne Expanded Clinical Study.
David W M Muller, Alison Duncan, Paul Sorajja, Gry Dahle, Vasilis Babaliaros
ESC Heart Failure. 2026-07-04
Impact of Adverse Events on Costs and Length of Stay Following Transcatheter Tricuspid Valve Replacement.
Matthew R Reynolds, Pinak B Shah, Susheel K Kodali, Rebecca T Hahn, Vinod H Thourani
Structural Heart. 2026-07-01

Journal Articles

Association of Effective Regurgitation Orifice Area to Left Ventricular End-Diastolic Volume Ratio with Transcatheter Mitral Valve Repair Outcomes
Joann Lindenfeld, William T Abraham, Paul A Grayburn, Federico M Asch, Gregg W Stone, JAMA Cardiology
Predictors of Clinical Response to Transcatheter Reduction of Secondary Mitral Regurgitation the COAPT Trial
Paul Grayburn, MD, Journal of the American College of Cardiology
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
JoAnn Lindenfeld, Saibal Kar, Michael J Mack, Samir R Kapadia, Gregg W Stone, Ian J Sarembock, William T Abraham, Andreas Brieke, David J Cohen, Steven O Marx, Brian W..., The New England Journal of Medicine

Lectures

Proportionate and Disproportionate FMR: A New Conceptual Framework to Explain Differences in Clinical Trial Outcomes
CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/12/2019
Plenary Lecture: Imaging Issues in Mitral Regurgitation and Impact on Trial Design
CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/12/2019
How Should We Define Severe MR?
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019

Authored Content

The Mechanism of Secondary MR Is Often MisdiagnosedDecember 2020
Predictors of Clinical Response to Transcatheter Reduction of Secondary Mitral Regurgitation the COAPT TrialSeptember 2020
Predictors of Clinical Response to Transcatheter Reduction of Secondary Mitral Regurgitation the COAPT TrialSeptember 2020

Press Mentions

Late-Breaking Clinical Trials Announced for New York Valves 2025June 17th, 2025
Optimizing Medical Therapy Before Clip Repair for MR? ‘This Is Hard’July 27th, 2021
Echo Features Pinpoint Those Unlikely to Benefit from MitraClipDecember 15th, 2020